Inhaled Long-acting Bronchodilators With or Without Inhaled Glucocorticosteroids for Preventing Hospitalizations and Death in Elderly Patients With Chronic Obstructive Pulmonary Disease
Recruiting
Università degli Studi di Ferrara
Phase 4
2018-11-11
This will be a phase IV, open label, multicenter, randomized pragmatic study in frail elderly
patients with COPD. Participants will be treated with either inhaled LABD alone or LABD
combined with inhaled glucocorticosteroids. The main aim of the study is to assess whether,
in elderly patients with COPD and one or more cardiac comorbidities (heart failure, and/or
ischemic heart disease, and/or atrial fibrillation) recently hospitalized because of an acute
exacerbation of COPD, 12 months treatment with LABD(s)+ICS can increase the time to first
re-hospitalization (all cause) and/or death for any cause when compared with LABD(s) alone.
Patients will be followed-up for 3 months after completion of the 12 month treatment period.
Lung Deposition of TRIMBOW® pMDI in Healthy Volunteers, Asthmatic and COPD Patients
Terminated
Chiesi Farmaceutici S.p.A.
Phase 1
2019-01-14
The purpose of this study is to investigate the lung deposition and distribution pattern of
TRIMBOW using a Gamma-scintigraphic technique after inhalation of a single dose of 99mTc
radiolabelled TRIMBOW administered via pMDI in healthy volunteers, asthmatic and COPD
patients
A Study Comparing the Effects of Trimbow to Fostair in COPD
Completed
Chiesi UK
Phase 4
2018-12-13
A randomised, open label 2-way cross-over study to compare the effects of inhaled
Beclometasone/Formoterol/Glycopyrronium (TRIMBOW) pMDI to Beclometasone/Formoterol (FOSTAIR)
pMDI on hyperinflation and expiratory flow limitation in moderate to severe chronic
obstructive pulmonary disease (COPD).
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models.
By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
